Cargando…
Monitoring the Coagulation Profile of COVID-19 Patients Using Standard and ClotPro(®) Hemostasis Tests
Background and Objectives: Coagulation disorders during COVID-19 infection are associated with a poorer prognosis and higher disease severity because thrombosis and inflammation are two processes that interfere with each other. A very important issue for clinicians is timely and adequate hemostasis...
Autores principales: | Milić, Dragan, Lazarević, Milan, Vuković, Natalija, Kamenov, Aleksandar, Perić, Velimir, Golubović, Mlađan, Stošić, Marija, Spasić, Dimitrije, Stojiljković, Vladimir, Stokanović, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386453/ https://www.ncbi.nlm.nih.gov/pubmed/37512014 http://dx.doi.org/10.3390/medicina59071202 |
Ejemplares similares
-
Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
por: Infanger, Lukas, et al.
Publicado: (2021) -
A Risk Stratification Model for Cardiovascular Complications during the 3-Month Period after Major Elective Vascular Surgery
por: Golubovic, Mladjan, et al.
Publicado: (2018) -
Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting
Assay: A Prospective, Single-Arm, Open-Label Study
por: Fong, Alan Yean Yip, et al.
Publicado: (2020) -
A comparison of the ClotPro system with rotational thromboelastometry in cardiac surgery: a prospective observational study
por: Yoshii, Ryogo, et al.
Publicado: (2022) -
Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro(®) Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients
por: Oberladstätter, Daniel, et al.
Publicado: (2021)